Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon

Infection and Immunity

Volumn 69, Issue 12, 2001, Pages 7927-7932

  Pantoja, L G ^a   Miller, R D ^a   Ramirez, J A ^a   Molestina, R E ^a   Summersgill, J T ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ARTICLE; ATHEROSCLEROSIS; BACTERIAL GROWTH; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RISK FACTOR; ULTRASTRUCTURE;

CHLAMYDOPHILA PNEUMONIAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INCLUSION BODIES; INTERFERON TYPE II; LARYNGEAL NEOPLASMS; TRYPTOPHAN OXYGENASE; TUMOR CELLS, CULTURED;

EID: 0035183125     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.12.7927-7932.2001     Document Type: Article

References (34)

1. Reactivation of persistent Chlamydia trachomatis infection in cell culture
2. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence
3. Morphologic and antigenic characterization of IFN gamma mediated persistent C. trachomatis infection in vitro
4. Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection
5. Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis
6. Induction of tryptophan catabolism is the mechanism for gamma interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells
7. 1-Methyl-DL-tryptophan, β-(3-benzofuranyl)-DS-alanine (the oxygen analog of tryptophan), and β- [3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase
8. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
9. Effects of penicillin on the synthesis of membrane proteins of Chlamydia trachomatis LGV2 serotype
10. Persistence of Chlamydia trachomatis is induced by ciprofloxacin in vitro
11. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
12. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae
13. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts
14. Expression and regulation of interferon-gamma-induced tryptophan catabolism in cultured skin fibroblasts
15. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
16. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae
17. Induction of macrophage foam cell formation by Chlamydia pneumoniae
18. The signal transduction mechanism responsible for gamma-interferon-induced indoleamine 2,3-dioxygenase gene expression
19. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
20. Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae
21. Differential expression of ompA, ompB, pyk, n1pD and Cpn0585 genes between normal and interferon-gamma-treated cultures of C. pneumoniae
22. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: Role of tryptophan catabolism
23. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis
24. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes
25. Pathogenesis of atherosclerosis: A possible relation to infection
26. Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures
27. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma-interferon induced indoleamine 2,3-dioxyenase activity
28. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
29. Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp.
30. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
31. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
32. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha
33. IFN-γ-mediated antimicrobial response: Indoleamine 2,3-dioxygenase-deficient mutants no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth
34. Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells